Studying psychedelics holistically
Expertise
CU Psychedelics Summit Showcases Leadership in Emerging Field
In a moment that brought together scientists and educators from across Colorado, the CU Psychedelics Summit marked a milestone in the state's leadership in psychedelic research and education. Hosted by CU Anschutz and featuring contributions from every campus in the CU System, the one-day summit reflected the energy and expertise that's making Colorado a national model for safe and effective psychedelic research. Read more
The transdisciplinary team at the Center for Psychedelic Research is comprised of leading experts in
- psychology
- medicine
- psychoneuroimmunology
- behavioral neuroendocrinology
- and public policy
who study the use of psychedelics holistically.
Our program is grounded in science and focused on the effects of these interventions on the quality of human life. The Center director is a co-principal investigator of a Colorado- and New York-based team leading the nation's largest study on the therapeutic use of psilocybin among patients facing the end of life.
The regulatory environment
In 2022, voters in Colorado approved Proposition 122, which decriminalized the use of psilocybin-containing "magic mushrooms" and other plant and fungal psychedelic substances. The law established a Division of Natural Medicine to create a framework for the use of these psychedelics in mental health and therapeutic settings.
CU Denver Center for Psychedelic Research is an authorized organization training both licensed and unlicensed individuals to use natural psychedelics in controlled settings.
Findings from all the Center's research are shared with stakeholders, government agencies including the FDA, Medicare/Medicaid, and others to inform public policy regarding the responsible and equitable use of these drugs.
We welcome collaborations with other organizations and individuals.